Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997

Microbes and Infection

Volumn 8, Issue 8, 2006, Pages 2082-2087

  Lin, Yu Chi ^a   Yao, Shu Man ^a   Yan, Jer Jea ^a   Chen, Ying Yan ^a   Hsiao, Miao Ju ^a   Chou, Chen Ying ^a   Su, Hsun Pi ^a   Wu, Ho Shen ^a   Li, Shu Ying ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

Antigenic divergence; Molecular epidemiology; Pertussis; Vaccine

Indexed keywords

ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; EPIDEMIC; GENE SEQUENCE; INCIDENCE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FIMBRIAE PROTEINS; HUMANS; INCIDENCE; INFANT; MOLECULAR EPIDEMIOLOGY; SEQUENCE ANALYSIS, DNA; TAIWAN; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

BORDETELLA PERTUSSIS;

EID: 33748127056     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.03.019     Document Type: Article

References (35)

1. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18 (2005) 326-382
2. Kerr J.R., and Matthews R.R. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 77-88
3. Lai H.K., and Tsai S.F. Epidemiology of pertussis in Taiwan, 1993-1998, and its control measures. Epidemiol. Bull. 16 (2000) 255-281
4. van Amersfoorth S.C., Schouls L.M., van der Heide H.G., Advani A., Hallander H.O., Bondeson K., von Konig C.H., Riffelmann M., Vahrenholz C., Guiso N., Caro V., Njamkepo E., He Q., Mertsola J., and Mooi F.R. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 43 (2005) 2837-2843
5. Weber C., Boursaux-Eude C., Coralie G., Caro V., and Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39 (2001) 4396-4403
6. Rohani P., Earn D.J., and Grenfell B.T. Impact of immunisation on pertussis transmission in England and Wales. Lancet 355 (2000) 285-286
7. Rohani P., Earn D.J., and Grenfell B.T. Opposite patterns of synchrony in sympatric disease metapopulations. Science 286 (1999) 968-971
8. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., Wharton M., and Livengood J.R. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 28 (1999) 1230-1237
9. Cassiday P., Sanden G., Heuvelman K., Mooi F., Bisgard K.M., and Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J. Infect. Dis. 182 (2000) 1402-1408
10. Mooi F.R., van Loo I.H., and King A.J. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?. Emerg. Infect. Dis. 7 (2001) 526-528
11. Mooi F.R., He Q., van Oirschot H., and Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 67 (1999) 3133-3134
12. Elomaa A., Advani A., Donnelly D., Antila M., Mertsola J., Hallander H., ., and He Q. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J. Clin. Microbiol. 43 (2005) 3681-3687
13. de Melker H.E., Schellekens J.F., Neppelenbroek S.E., Mooi F.R., Rumke H.C., and Conyn-van Spaendonck M.A. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg. Infect. Dis. 6 (2000) 348-357
14. von Konig C.H., Halperin S., Riffelmann M., and Guiso N. Pertussis of adults and infants. Lancet Infect. Dis. 2 (2002) 744-750
15. De Serres G., Shadmani R., Duval B., Boulianne N., Dery P., Douville F.M., Rochette L., and Halperin S.A. Morbidity of pertussis in adolescents and adults. J. Infect. Dis. 182 (2000) 174-179
16. Hu J.J., Lu C.Y., Chang L.Y., Huang C.H., Chou C.C., Huang F.Y., Lee C.Y., and Huang L.M. Survey of pertussis in patients with prolonged cough. J. Microbiol. Immunol. Infect. 39 (2006) 54-58
17. Yao S.M., Lin Y.C., Chou C.Y., Chen Y.Y., Hsiao M.J., Chen H.Y., Yan J.J., Su H.P., and Li S.Y., Antigenic divergence of Bordetella pertussis isolates in Taiwan. J. Clin. Microbiol. 43 (2005) 5457-5461
18. Mooi F.R., Hallander H., Wirsing von Konig C.H., Hoet B., and Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 174-181
19. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm. Rep. 46 (1997) 1-55
20. Fry N.K., Neal S., Harrison T.G., Miller E., Matthews R., and George R.C. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun. 69 (2001) 5520-5528
21. Hallander H.O., Advani A., Donnelly D., Gustafsson L., and Carlsson R.M. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol. 43 (2005) 2856-2865
22. Hardwick T.H., Cassiday P., Weyant R.S., Bisgard K.M., and Sanden G.N. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg. Infect. Dis. 8 (2002) 44-49
23. Mooi F.R., van Oirschot H., Heuvelman K., van der Heide H.G., Gaastra W., and Willems R.J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66 (1998) 670-675
24. Kodama A., Kamachi K., Horiuchi Y., Konda T., and Arakawa Y. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J. Clin. Microbiol. 42 (2004) 5453-5457
25. King A.J., Berbers G., van Oirschot H.F., Hoogerhout P., Knipping K., and Mooi F.R. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147 (2001) 2885-2895
26. Tiru M., Askelof P., Granstrom M., and Hallander H. Bordetella pertussis serotype of clinical isolates in Sweden during 1970-1995 and influence of vaccine efficacy studies. Dev. Biol. Stand. 89 (1997) 239-245
27. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., and Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334 (1996) 349-355
28. Van Loo I.H., and Mooi F.R. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 148 (2002) 2011-2018
29. Poynten M., McIntyre P.B., Mooi F.R., Heuvelman K.J., and Gilbert G.L. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol. Infect. 132 (2004) 185-193
30. Tsang R.S., Lau A.K., Sill M.L., Halperin S.A., Van Caeseele P., Jamieson F., and Martin I.E. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J. Clin. Microbiol. 42 (2004) 5364-5367
31. Bisgard K.M., Christie C.D., Reising S.F., Sanden G.N., Cassiday P.K., Gomersall C., Wattigney W.A., Roberts N.E., and Strebel P.M. Molecularepidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J. Infect. Dis. 183 (2001) 1360-1367
32. Lee Y.S., Yang C.Y., Lu C.H., and Tseng Y.H. Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992-1997. Microbiol. Immunol. 47 (2003) 903-909
33. Caro V., Njamkepo E., Van Amersfoorth S.C., Mooi F.R., Advani A., Hallander H.O., He Q., Mertsola J., Riffelmann M., Vahrenholz C., Von Konig C.H., and Guiso N. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes. Infect. 7 (2005) 976-982
34. Schouls L.M., van der Heide H.G., Vauterin L., Vauterin P., and Mooi F.R. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J. Bacteriol. 186 (2004) 5496-5505
35. van Loo I.H., Heuvelman K.J., King A.J., and Mooi F.R. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol. 40 (2002) 1994-2001